BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Xianfeng Fang, Pan Zheng, Jie Tang, Yang Liu. CD24: from A to ZCellular & Molecular Immunology 2010; 7(2): 100 doi: 10.1038/cmi.2009.119
2
S Buczacki, R J Davies, D J Winton. Stem cells, quiescence and rectal carcinoma: an unexplored relationship and potential therapeutic targetBritish Journal of Cancer 2011; 105(9): 1253 doi: 10.1038/bjc.2011.362
3
Brijnandan Gupta, Prasenjit Das, Shouriyo Ghosh, Janvie Manhas, Sudip Sen, Sujoy Pal, Peush Sahni, Aashish Dutt Upadhyay, Subrat K. Panda, Siddhartha Datta Gupta. Identification of High-Risk Aberrant Crypt Foci and Mucin-Depleted Foci in the Human Colon With Study of Colon Cancer Stem Cell MarkersClinical Colorectal Cancer 2017; 16(3): 204 doi: 10.1016/j.clcc.2016.09.001
4
Shirin Mahmoodi, Navid Nezafat, Manica Negahdaripour, Younes Ghasemi. A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens PropertiesCurrent Molecular Medicine 2019; 19(1): 2 doi: 10.2174/1566524019666190204114721
5
Said Abdullah Khelwatty, Sharadah Essapen, Izhar Bagwan, Margaret Green, Alan M. Seddon, Helmout Modjtahedi. Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancerOncotarget 2019; 10(18): 1704 doi: 10.18632/oncotarget.26722
6
Gokulan Ravindran, Halagowder Devaraj. Aberrant expression of CD133 and musashi-1 in preneoplastic and neoplastic human oral squamous epithelium and their correlation with clinicopathological factorsHead & Neck 2012; 34(8): 1129 doi: 10.1002/hed.21896
7
Lulu Farhana, Pratima Nangia-Makker, Evan Arbit, Kathren Shango, Sarah Sarkar, Hamidah Mahmud, Timothy Hadden, Yingjie Yu, Adhip P. N. Majumdar. Bile acid: a potential inducer of colon cancer stem cellsStem Cell Research & Therapy 2016; 7(1) doi: 10.1186/s13287-016-0439-4
8
Nerea Bitarte, Eva Bandres, Valentina Boni, Ruth Zarate, Javier Rodriguez, Marisol Gonzalez-Huarriz, Ines Lopez, Jesus Javier Sola, Marta M. Alonso, Puri Fortes, Jesus Garcia-Foncillas. MicroRNA-451 Is Involved in the Self-renewal, Tumorigenicity, and Chemoresistance of Colorectal Cancer Stem CellsSTEM CELLS 2011; 29(11): 1661 doi: 10.1002/stem.741
9
Fabian Lang, Bartosch Wojcik, Michael A. Rieger. Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic LeukemiaStem Cells International 2015; 2015: 1 doi: 10.1155/2015/137164
10
Ke Wang, Jianjun Xu, Junshu Zhang, Jian Huang. Prognostic role of CD133 expression in colorectal cancer: a meta-analysisBMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-573
11
A. P. Davydov-Sinitsyn, O. V. Bajenova, M. A. Liskovykh, S. V. Ponomartsev, I. V. Rykov, S. A. Koshkin, R. V. Orlova, A. N. Tomilin, E. N. Tolkunova. Tumor growth suppression after xenografting of human colorectal carcinoma cellsCell and Tissue Biology 2015; 9(4): 318 doi: 10.1134/S1990519X15040045
12
Rongyong Huang, Dan Mo, Junrong Wu, Huaying Ai, Yiping Lu. CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patientsMedicine 2018; 97(23): e10446 doi: 10.1097/MD.0000000000010446
13
Kathryn E. Hamilton, Felicite K. Noubissi, Prateek S. Katti, Christopher M. Hahn, Sonya R. Davey, Emma T. Lundsmith, Andres J. Klein-Szanto, Andrew D. Rhim, Vladimir S. Spiegelman, Anil K. Rustgi. IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenograftsCarcinogenesis 2013; 34(11): 2647 doi: 10.1093/carcin/bgt217
14
Danysh Abetov, Zhanar Mustapova, Timur Saliev, Denis Bulanin. Biomarkers and signaling pathways of colorectal cancer stem cellsTumor Biology 2015; 36(3): 1339 doi: 10.1007/s13277-015-3198-4
15
Aristides G. Vaiopoulos, Ioannis D. Kostakis, Michael Koutsilieris, Athanasios G. Papavassiliou. Colorectal Cancer Stem CellsSTEM CELLS 2012; 30(3): 363 doi: 10.1002/stem.1031
16
Afshin Habibi, Nastaran Ranjbari, Fakher Rahim, Nematollah Jazayeri. Correlation between CD34 Marker and Clinico-Pathologic Characteristics of Gastric CancerInternational Journal of Cancer Research 2015; 11(3): 136 doi: 10.3923/ijcr.2015.136.142
17
Matilde Todaro, Maria Giovanna Francipane, Jan Paul Medema, Giorgio Stassi. Colon Cancer Stem Cells: Promise of Targeted TherapyGastroenterology 2010; 138(6): 2151 doi: 10.1053/j.gastro.2009.12.063
18
SHU-CHUAN TSAO, CHUN-CHIEH WU, CHIEN-HUI WEN, YA-CHUN HUANG, CHEE-YIN CHAI. A simple and economical method for the manual construction of frozen tissue arraysAPMIS 2010; 118(10): 739 doi: 10.1111/j.1600-0463.2010.02652.x
19
Yalan Bi, Yunxiao Meng, Huanwen Wu, Quancai Cui, Yufeng Luo, Xiaowei Xue. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysisJournal of Surgical Oncology 2016; 113(2): 144 doi: 10.1002/jso.24124
20
Lucinei R. Oliveira, João P. Oliveira-Costa, Iana M. Araujo, Danilo F. Soave, Juliana S. Zanetti, Fernando A. Soares, Sérgio Zucoloto, Alfredo Ribeiro-Silva. Cancer stem cell immunophenotypes in oral squamous cell carcinomaJournal of Oral Pathology & Medicine 2011; 40(2): 135 doi: 10.1111/j.1600-0714.2010.00967.x
21
Yijun Hu, Xiya Yu, Shupeng Liu, Shanrong Liu. Cancer stem cells: A shifting subpopulation of cells with stemness?Medical Hypotheses 2013; 80(5): 649 doi: 10.1016/j.mehy.2013.01.009
22
Amy V. Paschall, Dafeng Yang, Chunwan Lu, Priscilla S. Redd, Jeong-Hyeon Choi, Christopher M. Heaton, Jeffrey R. Lee, Asha Nayak-Kapoor, Kebin Liu. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotypeOncotarget 2016; 7(48): 78698 doi: 10.18632/oncotarget.12168
23
D. Spiegelberg, G. Kuku, R. Selvaraju, M. Nestor. Characterization of CD44 variant expression in head and neck squamous cell carcinomasTumor Biology 2014; 35(3): 2053 doi: 10.1007/s13277-013-1272-3
24
FEIFENG JING, HUN JIN KIM, CHANG HYUN KIM, YOUNG JIN KIM, JAE HYUK LEE, HYEONG ROK KIM. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastasesInternational Journal of Oncology 2015; 46(4): 1582 doi: 10.3892/ijo.2015.2844
25
Yang Zhao, Jing Peng, Enlong Zhang, Ning Jiang, Jiang Li, Qi Zhang, Xuening Zhang, Yuanjie Niu. CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysisOncotarget 2016; 7(9): 10023 doi: 10.18632/oncotarget.7054
26
Jaromir Hacek, Antonin Brisuda, Marek Babjuk, Josef Zamecnik. Expression of cancer stem cells markers in urinary bladder urothelial carcinoma and its precursor lesionsBiomedical Papers 2020;  doi: 10.5507/bp.2020.017
27
Youness Azimzade, Abbas Ali Saberi, Muhammad Sahimi. Role of the Interplay Between the Internal and External Conditions in Invasive Behavior of TumorsScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24418-8
28
Yuichiro Hatano, Shinya Fukuda, Kenji Hisamatsu, Akihiro Hirata, Akira Hara, Hiroyuki Tomita. Multifaceted Interpretation of Colon Cancer Stem CellsInternational Journal of Molecular Sciences 2017; 18(7): 1446 doi: 10.3390/ijms18071446
29
Aneet Mann, Randy van Ommeren, Branavan Manoranjan, Nicole McFarlane, Parvez Vora, Chitra Venugopal, Sheila Singh. Cancer Stem Cells2014; : 193 doi: 10.1002/9781118356203.ch15
30
Youn Young Park, Chang Hyeok An, Seong Taek Oh, Eun Deock Chang, Jaeim Lee. Expression of CD133 is associated with poor prognosis in stage II colorectal carcinomaMedicine 2019; 98(32): e16709 doi: 10.1097/MD.0000000000016709
31
Ning Su, Liang Peng, Bingqing Xia, Yingying Zhao, Angao Xu, Jing Wang, Xinying Wang, Bo Jiang. Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancerMolecular Cancer 2012; 11(1): 43 doi: 10.1186/1476-4598-11-43
32
April Adams, Kristy Warner, Alexander T. Pearson, Zhaocheng Zhang, Hong Sun Kim, Daiki Mochizuki, Gregory Basura, Joseph Helman, Andrea Mantesso, Rogério M. Castilho, Max S. Wicha, Jacques E. Nör. ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomasOncotarget 2015; 6(29): 26633 doi: 10.18632/oncotarget.5782
33
S.M. Riajul Wahab, Farhadul Islam, Vinod Gopalan, Alfred King-yin Lam. The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal CancerClinical Colorectal Cancer 2017; 16(2): 93 doi: 10.1016/j.clcc.2017.01.011
34
Fatemeh B. Rassouli, Maryam M. Matin, Morvarid Saeinasab. Cancer stem cells in human digestive tract malignanciesTumor Biology 2016; 37(1): 7 doi: 10.1007/s13277-015-4155-y
35
Safia Salaria, Anna Means, Frank Revetta, Kamran Idrees, Eric Liu, Chanjuan Shi. Expression of CD24, a Stem Cell Marker, in Pancreatic and Small Intestinal Neuroendocrine TumorsAmerican Journal of Clinical Pathology 2015; 144(4): 642 doi: 10.1309/AJCPMZY5P9TWNJJV
36
Julie Pannequin. Cellules souches cancéreuses et cancer du côlonBulletin du Cancer 2017; 104(12): 1072 doi: 10.1016/j.bulcan.2017.10.016
37
Danilo Figueiredo Soave, João Paulo Oliveira da Costa, Giorgia Gobbi da Silveira, Renata Carolina Fraga Ianez, Lucinei Roberto de Oliveira, Silvia Vanessa Lourenço, Alfredo Ribeiro-Silva. CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasmsDiagnostic Pathology 2013; 8(1) doi: 10.1186/1746-1596-8-29
38
Juanjuan Ou, Jia Deng, Xing Wei, Ganfeng Xie, Rongbin Zhou, Liqing Yu, Houjie Liang. Fibronectin extra domain A (EDA) sustains CD133+/CD44+ subpopulation of colorectal cancer cellsStem Cell Research 2013; 11(2): 820 doi: 10.1016/j.scr.2013.05.009
39
Ryo Seishima, Koji Okabayashi, Osamu Nagano, Hirotoshi Hasegawa, Masashi Tsuruta, Masayuki Shimoda, Kaori Kameyama, Hideyuki Saya, Yuko Kitagawa. Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9+ cancer stem cells in ulcerative colitis-related cancerClinics and Research in Hepatology and Gastroenterology 2016; 40(4): 487 doi: 10.1016/j.clinre.2015.11.007
40
Thomas B. Brunner, Leoni A. Kunz-Schughart, Philipp Grosse-Gehling, Michael Baumann. Cancer Stem Cells as a Predictive Factor in RadiotherapySeminars in Radiation Oncology 2012; 22(2): 151 doi: 10.1016/j.semradonc.2011.12.003
41
Alessandro Sgambato, Maddalena Corbi, Maria Svelto, Emanuele Caredda, Achille Cittadini. Prominin-1 (CD133): New Insights on Stem & Cancer Stem Cell BiologyAdvances in Experimental Medicine and Biology 2013; 777: 145 doi: 10.1007/978-1-4614-5894-4_10
42
Yuehua Gong, Ying Guo, Yanan Hai, Hao Yang, Yang Liu, Shi Yang, Zhenzhen Zhang, Meng Ma, Linhong Liu, Zheng Li, Zuping He. Nodal Promotes the Self-Renewal of Human Colon Cancer Stem Cells via an Autocrine Manner through Smad2/3 Signaling PathwayBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/364134
43
Antonija Kreso, Liane Gibson, Catherine Adell O’Brien. Metastasis of Colorectal CancerCancer Metastasis - Biology and Treatment 2010; 14: 127 doi: 10.1007/978-90-481-8833-8_5
44
Shicai Chen, Xinming Song, Zhihui Chen, Xinxin Li, Mingzhe Li, Haiying Liu, Jianchang Li, Hiromu Suzuki. CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-AnalysisPLoS ONE 2013; 8(2): e56380 doi: 10.1371/journal.pone.0056380
45
Mohamed L. Salem, Ahmed S. El-Badawy, Zihai Li. Immunobiology and signaling pathways of cancer stem cells: implication for cancer therapyCytotechnology 2015; 67(5): 749 doi: 10.1007/s10616-014-9830-0
46
V. Moreno García, J. F. Batlle, E. Casado, E. Burgos, J. de Castro, C. Belda, J. Barriuso, J. J. Sánchez, M. Á. García-Cabezas, M. González-Barón, P. Cejas. Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapyColorectal Disease 2011; 13(9): 989 doi: 10.1111/j.1463-1318.2010.02386.x
47
Yumin Chung, Young Chan Wi, Yeseul Kim, Seong Sik Bang, Jung-Ho Yang, Kiseok Jang, Kyueng-Whan Min, Seung Sam Paik. The Smad4/PTEN Expression Pattern Predicts Clinical Outcomes in Colorectal AdenocarcinomaJournal of Pathology and Translational Medicine 2018; 52(1): 37 doi: 10.4132/jptm.2017.10.20
48
Po Zhao, Yazhuo Li, Yali Lu. Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinomaBMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-218
49
Morteza Akbari, Navid Shomali, Afsaneh Faraji, Dariush Shanehbandi, Milad Asadi, Ahad Mokhtarzadeh, Aliakbar Shabani, Behzad Baradaran. CD133: An emerging prognostic factor and therapeutic target in colorectal cancerCell Biology International 2020; 44(2): 368 doi: 10.1002/cbin.11243
50
Arianna Casciati, Mirella Tanori, Rémi Manczak, Sofiane Saada, Barbara Tanno, Paola Giardullo, Elena Porcù, Elena Rampazzo, Luca Persano, Giampietro Viola, Claire Dalmay, Fabrice Lalloué, Arnaud Pothier, Caterina Merla, Mariateresa Mancuso. Human Medulloblastoma Cell Lines: Investigating on Cancer Stem Cell-Like PhenotypeCancers 2020; 12(1): 226 doi: 10.3390/cancers12010226
51
Juntao Lang, Xiaoli Lan, Yu Liu, Xueyan Jin, Tao Wu, Xun Sun, Qiong Wen, Rui An. Targeting cancer stem cells with an 131 I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenograftsNuclear Medicine and Biology 2015; 42(5): 505 doi: 10.1016/j.nucmedbio.2015.01.003
52
S. Ramalingam, G. W. Daughtridge, M. J. Johnston, A. D. Gracz, S. T. Magness. Distinct levels of Sox9 expression mark colon epithelial stem cells that form colonoids in cultureAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 302(1): G10 doi: 10.1152/ajpgi.00277.2011
53
Junko Kishikawa, Shinsuke Kazama, Koji Oba, Kiyoshi Hasegawa, Hiroyuki Anzai, Yuzo Harada, Hiroyuki Abe, Keisuke Matsusaka, Kumiko Hongo, Masaru Oba, Koji Yasuda, Kensuke Otani, Takeshi Nishikawa, Toshiaki Tanaka, Junichiro Tanaka, Tomomichi Kiyomatsu, Keisuke Hata, Kazushige Kawai, Hiroaki Nozawa, Hironori Yamaguchi, Soichiro Ishihara, Eiji Sunami, Tetsuo Ushiku, Joji Kitayama, Masashi Fukayama, Norihiro Kokudo, Toshiaki Watanabe. CD133 Expression at the Metastatic Site Predicts Patients’ Outcome in Colorectal Cancer with Synchronous Liver MetastasisAnnals of Surgical Oncology 2016; 23(6): 1916 doi: 10.1245/s10434-016-5099-1
54
V Boncheva, S A Bonney, S E Brooks, M Tangney, G O'Sullivan, A Mirnezami, B-A Guinn. New targets for the immunotherapy of colon cancer—does reactive disease hold the answer?Cancer Gene Therapy 2013; 20(3): 157 doi: 10.1038/cgt.2013.5
55
Jin-Hai Zhai, Wen-Chao Gu, Xiao-Lin Xu, Jiang Wu, Xue-Jun Hu, Ke-Zhu Hou. RETRACTED ARTICLE: Prognostic value of CD133 expression in cancer patients treated with chemoradiotherapy: a meta-analysisTumor Biology 2015; 36(2): 701 doi: 10.1007/s13277-014-2251-z
56
Xiao-Song Wu, Hong-Qing Xi, Lin Chen. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survivalWorld Journal of Surgical Oncology 2012; 10(1): 244 doi: 10.1186/1477-7819-10-244
57
Alireza Mirzaei, Gholamreza Tavoosidana, Mohammad Hossein Modarressi, Afshin Abdi Rad, Mohammad Sadegh Fazeli, Reza Shirkoohi, Masoumeh Tavakoli-Yaraki, Zahra Madjd. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patientsTumor Biology 2015; 36(6): 4801 doi: 10.1007/s13277-015-3132-9
58
S. Di Franco, M. Todaro, F. Dieli, G. Stassi. Colorectal cancer defeating? Challenge accepted!Molecular Aspects of Medicine 2014; 39: 61 doi: 10.1016/j.mam.2013.07.001
59
Cristina Maccalli, Andrea Volontè, Carolina Cimminiello, Giorgio Parmiani. Immunology of cancer stem cells in solid tumours. A reviewEuropean Journal of Cancer 2014; 50(3): 649 doi: 10.1016/j.ejca.2013.11.014
60
Karen Bento Ribeiro, Juliana da Silva Zanetti, Alfredo Ribeiro-Silva, Liane Rapatoni, Harley Francisco de Oliveira, Daniela Pretti da Cunha Tirapelli, Sergio Britto Garcia, Omar Feres, José Joaquim Ribeiro da Rocha, Fernanda Maris Peria. KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancerCancer Biomarkers 2016; 16(4): 513 doi: 10.3233/CBM-160592
61
Sumei Lu, Jiajun Tian, Zhenghua Lv, Haibo Wang, Xiaohui Bai, Wenwen Liu, Jianfeng Li, Wei Xu. The Probable Role of Tumor Stem Cells for Lymph Node Metastasis in Supraglottic CarcinomaPathology & Oncology Research 2011; 17(1): 33 doi: 10.1007/s12253-010-9271-9
62
Nobuhiro Torata, Kenoki Ohuchida, Shin Akagawa, Lin Cui, Shingo Kozono, Kazuhiro Mizumoto, Shinichi Aishima, Yoshinao Oda, Masao Tanaka. Tissue tablet method: an efficient tissue banking procedure applicable to both molecular analysis and frozen tissue microarrayHuman Pathology 2014; 45(1): 143 doi: 10.1016/j.humpath.2013.08.013
63
Margaret L. Thomas, Krysta M. Coyle, Mohammad Sultan, Paola Marcato. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology2015; : 477 doi: 10.1007/978-3-319-21030-8_17
64
Appalaraju Jaggupilli, Eyad Elkord. Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring AmbiguityClinical and Developmental Immunology 2012; 2012: 1 doi: 10.1155/2012/708036
65
Sara Häggblad Sahlberg, Diana Spiegelberg, Bengt Glimelius, Bo Stenerlöw, Marika Nestor, Andrew Yeudall. Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer CellsPLoS ONE 2014; 9(4): e94621 doi: 10.1371/journal.pone.0094621
66
Sonya A Hubbard, Caroline E Gargett. A cancer stem cell origin for human endometrial carcinoma?REPRODUCTION 2010; 140(1): 23 doi: 10.1530/REP-09-0411
67
KEITA TODOROKI, SACHIKO OGASAWARA, JUN AKIBA, MASAMICHI NAKAYAMA, YOSHIKI NAITO, NAOKO SEKI, JINGO KUSUKAWA, HIROHISA YANO. CD44v3+/CD24− cells possess cancer stem cell-like properties in human oral squamous cell carcinomaInternational Journal of Oncology 2016; 48(1): 99 doi: 10.3892/ijo.2015.3261
68
Zhenpeng Wang, Yufei Tang, Lei Xie, Aiping Huang, Chunchun Xue, Zhen Gu, Kaiqiang Wang, Shaoqi Zong. The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-AnalysisFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00309
69
Kumiko Hongo, Junichiro Tanaka, Nelson H. Tsuno, Kazushige Kawai, Takeshi Nishikawa, Yasutaka Shuno, Kazuhito Sasaki, Manabu Kaneko, Masaya Hiyoshi, Eiji Sunami, Joji Kitayama, Koki Takahashi, Hirokazu Nagawa. CD133(−) Cells, Derived From a Single Human Colon Cancer Cell Line, Are More Resistant to 5-Fluorouracil (FU) Than CD133(+) Cells, Dependent on the β1-Integrin SignalingJournal of Surgical Research 2012; 175(2): 278 doi: 10.1016/j.jss.2011.03.076
70
Seung Yeop Oh, Se Hwa Sohn, Hyunee Yim, Dakeun Lee, Kwang Wook Suh, Young Bae Kim. ALDH1 is a prognostic factor for patients treated with neoadjuvant chemoradiotherapy and radical resection for stage III rectal cancerJournal of Surgical Oncology 2015; 111(2): 243 doi: 10.1002/jso.23792
71
X. Wei, D. Dombkowski, K. Meirelles, R. Pieretti-Vanmarcke, P. P. Szotek, H. L. Chang, F. I. Preffer, P. R. Mueller, J. Teixeira, D. T. MacLaughlin, P. K. Donahoe. Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeuticsProceedings of the National Academy of Sciences 2010; 107(44): 18874 doi: 10.1073/pnas.1012667107
72
Jeffrey B. King, Richard J. von Furstenberg, Brian J. Smith, Kirk K. McNaughton, Joseph A. Galanko, Susan J. Henning. CD24 can be used to isolate Lgr5+ putative colonic epithelial stem cells in miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 303(4): G443 doi: 10.1152/ajpgi.00087.2012
73
Maria Giovanna Francipane, Denis Bulanin, Eric Lagasse. Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection PressureInternational Journal of Molecular Sciences 2019; 20(8): 1817 doi: 10.3390/ijms20081817
74
Shinsuke Kazama, Junko Kishikawa, Tomomichi Kiyomatsu, Kazushige Kawai, Hiroaki Nozawa, Soichiro Ishihara, Toshiaki Watanabe. Expression of the stem cell marker CD133 is related to tumor development in colorectal carcinogenesisAsian Journal of Surgery 2018; 41(3): 274 doi: 10.1016/j.asjsur.2016.12.002
75
L Florianova, M Orain, B Têtu, CJ Doillon. Histological study of stem-like cells in human colon adenocarcinoma at different stages of the diseaseBiotechnic & Histochemistry 2013; 88(5): 222 doi: 10.3109/10520295.2012.758310
76
Jinhua Wang, Yajing Xing, Yingying Wang, Yundong He, Liting Wang, Shihong Peng, Lianfang Yang, Jiuqing Xie, Xiaotao Li, Wenwei Qiu, Zhengfang Yi, Mingyao Liu. A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancerJournal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1392-8
77
Rashmi K Ambasta, Archita Sharma, Pravir Kumar. Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapyVascular Cell 2011; 3(1): 26 doi: 10.1186/2045-824X-3-26
78
A Lugli, G Iezzi, I Hostettler, M G Muraro, V Mele, L Tornillo, V Carafa, G Spagnoli, L Terracciano, I Zlobec. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancerBritish Journal of Cancer 2010; 103(3): 382 doi: 10.1038/sj.bjc.6605762
79
Chih-Yung Yang, Chi-Hung Lin, Jeng-Kai Jiang. Early relapse in a rectal cancer patient: Possible implication of circulating cancer stem cellJournal of Surgical Oncology 2010; 102(2): 196 doi: 10.1002/jso.21597
80
Larissa Belov, Jerry Zhou, Richard I. Christopherson. Cell Surface Markers in Colorectal Cancer PrognosisInternational Journal of Molecular Sciences 2010; 12(1): 78 doi: 10.3390/ijms12010078
81
KAZUAKI HIROISHI, MASAFUMI INOMATA, KENJI KASHIMA, KAZUHIRO YASUDA, NORIO SHIRAISHI, SHIGEO YOKOYAMA, SEIGO KITANO. Cancer stem cell-related factors are associated with the efficacy of pre-operative chemoradiotherapy for locally advanced rectal cancerExperimental and Therapeutic Medicine 2011; 2(3): 465 doi: 10.3892/etm.2011.243
82
Hossein Keymoosi, Elmira Gheytanchi, Mojgan Asgari, Ahmad Shariftabrizi, Zahra Madjd. ALDH1 in Combination with CD44 as Putative Cancer Stem Cell Markers are Correlated with Poor Prognosis in Urothelial Carcinoma of the Urinary BladderAsian Pacific Journal of Cancer Prevention 2014; 15(5): 2013 doi: 10.7314/APJCP.2014.15.5.2013
83
Kumiko Hongo, Shinsuke Kazama, Eiji Sunami, Nelson H. Tsuno, Koki Takahashi, Hirokazu Nagawa, Joji Kitayama. Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancerMedical Oncology 2012; 29(4): 2849 doi: 10.1007/s12032-012-0161-8
84
Injae Hong, Seong Woo Hong, Yeo Goo Chang, Woo Yong Lee, Byungmo Lee, Yun Kyung Kang, You Sun Kim, In Wook Paik, Hyucksang Lee. Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining AnalysisAnnals of Coloproctology 2015; 31(3): 84 doi: 10.3393/ac.2015.31.3.84
85
Guangqiu Li, Chao Liu, Jian Yuan, Xiaoqin Xiao, Na Tang, Junmei Hao, Hongwei Wang, Xiuwu Bian, Yongjian Deng, Yanqing Ding. CD133+ single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potentialClinical & Experimental Metastasis 2010; 27(7): 517 doi: 10.1007/s10585-010-9341-0
86
Shan-Shan Zhang, Zai-Wei Huang, Li-Xuan Li, Jin-Jin Fu, Bing Xiao. Identification of CD200+ colorectal cancer stem cells and their gene expression profileOncology Reports 2016; 36(4): 2252 doi: 10.3892/or.2016.5039
87
Mitra Mehrazma, Zahra Madjd, Elham Kalantari, Mahshid Panahi, Alireza Hendi, Ahmad Shariftabrizi. Expression of Stem Cell Markers, CD133 and CD44, in Pediatric Solid Tumors: A Study Using Tissue MicroarrayFetal and Pediatric Pathology 2013; 32(3): 192 doi: 10.3109/15513815.2012.701266
88
Christina Karamboulas, Laurie Ailles. Developmental signaling pathways in cancer stem cells of solid tumorsBiochimica et Biophysica Acta (BBA) - General Subjects 2013; 1830(2): 2481 doi: 10.1016/j.bbagen.2012.11.008
89
S.S. Mitra, J.Q. He, R. Esparza, G. Hutter, S.H. Cheshier, I. Weissman. Cancer Stem Cells2016; : 3 doi: 10.1016/B978-0-12-803892-5.00001-2
90
Hyuk Hur, Inna Tulina, Min Soo Cho, Byung Soh Min, Woong Sub Koom, Joon Seok Lim, Joong Bae Ahn, Nam Kyu Kim. Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction AnalysisDiseases of the Colon & Rectum 2016; 59(12): 1174 doi: 10.1097/DCR.0000000000000711
91
YUHANG MA, XUEJIAO WANG, YONGDE PENG, XIAOYING DING. Forkhead box O1 promotes INS-1 cell apoptosis by reducing the expression of CD24Molecular Medicine Reports 2016; 13(4): 2991 doi: 10.3892/mmr.2016.4896
92
Shilpa Ravindran, Saad Rasool, Cristina Maccalli. The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with ImmunotherapyCancer Microenvironment 2019; 12(2-3): 133 doi: 10.1007/s12307-019-00233-1
93
Giuditta Mannelli, Oreste Gallo. Cancer stem cells hypothesis and stem cells in head and neck cancersCancer Treatment Reviews 2012; 38(5): 515 doi: 10.1016/j.ctrv.2011.11.007
94
Dina Mohamed Abdallah, Haitham Badawy, Shady Fadel, Hazem El Akaad. The expression of stem cell markers CD133 and Nestin in peripheral neuroblastic tumorsEgyptian Journal of Pathology 2011; 31(2): 118 doi: 10.1097/01.XEJ.0000406596.11732.fb
95
M Ozawa, Y Ichikawa, Y-W Zheng, T Oshima, H Miyata, K Nakazawa, H-B Guan, M Shiozawa, M Akaike, K Watanabe, M Ota, S Fujii, C Kunisaki, T Ishikawa, K Tanaka, H Akiyama, I Endo, H Taniguchi. Prognostic significance of CD44 variant 2 upregulation in colorectal cancerBritish Journal of Cancer 2014; 111(2): 365 doi: 10.1038/bjc.2014.253
96
Antonio Ieni, Giovanni Tuccari. Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer"Journal of Breast Cancer 2016; 19(1): 96 doi: 10.4048/jbc.2016.19.1.96
97
Saad Rasool, Sergio Rutella, Soldano Ferrone, Cristina Maccalli. Cancer Stem Cell Resistance to Targeted TherapyResistance to Targeted Anti-Cancer Therapeutics 2019; 19: 223 doi: 10.1007/978-3-030-16624-3_9
98
Hong Li, Po Zhao, Yang Lu, Yali Lu. Correlation of aberrant expression of CD133 with FHIT and malignant phenotype of colorectal adenocarcinomaInternational Journal of Colorectal Disease 2012; 27(8): 1015 doi: 10.1007/s00384-012-1421-y
99
Veronica Catalano, Cecilia Eleuteri, Gaia Campoccia, Gianluca Giacobini, Mariangela Zane, Giorgio Stassi, Giorgio Parmiani, Cristina Maccalli. Resistance of Cancer Cells to CTL-Mediated ImmunotherapyResistance to Targeted Anti-Cancer Therapeutics 2015; 7: 3 doi: 10.1007/978-3-319-17807-3_1
100
Hitoshi Kitamura, Koji Okudela, Takuya Yazawa, Hanako Sato, Hiroaki Shimoyamada. Cancer stem cell: Implications in cancer biology and therapy with special reference to lung cancerLung Cancer 2009; 66(3): 275 doi: 10.1016/j.lungcan.2009.07.019
101
Sirichat Kaowinn, Eun Jin Seo, Woong Heo, Jae-Ho Bae, Eun-Jung Park, Soojin Lee, Yeon Jeong Kim, Sang Seok Koh, Il Ho Jang, Dong Hoon Shin, Young-Hwa Chung. Cancer upregulated gene 2 (CUG2), a novel oncogene, promotes stemness-like properties via the NPM1-TGF-β signaling axisBiochemical and Biophysical Research Communications 2019; 514(4): 1278 doi: 10.1016/j.bbrc.2019.05.091
102
Po Zhao, Yali Lu, Weidong Han. Clinicopathological significance and prognostic value of leukemia-related protein 16 expression in invasive ductal breast carcinomaCancer Science 2010; 101(10): 2262 doi: 10.1111/j.1349-7006.2010.01658.x
103
Miana Gabriela Pop. Basic Principles and Practice in Surgery2019;  doi: 10.5772/intechopen.84315
104
Shu-Wen Jao, Su-Feng Chen, Yaoh-Shiang Lin, Yun-Ching Chang, Tsai-Yu Lee, Chang-Chieh Wu, Jong-Shiaw Jin, Shin Nieh. Cytoplasmic CD133 Expression is a Reliable Prognostic Indicator of Tumor Regression After Neoadjuvant Concurrent Chemoradiotherapy in Patients with Rectal CancerAnnals of Surgical Oncology 2012; 19(11): 3432 doi: 10.1245/s10434-012-2394-3
105
Hidekazu Takahashi, Hideshi Ishii, Naohiro Nishida, Ichiro Takemasa, Tsunekazu Mizushima, Masataka Ikeda, Takehiko Yokobori, Koshi Mimori, Hirofumi Yamamoto, Mitsugu Sekimoto, Yuichiro Doki, Masaki Mori. Significance of Lgr5+ve Cancer Stem Cells in the Colon and RectumAnnals of Surgical Oncology 2011; 18(4): 1166 doi: 10.1245/s10434-010-1373-9
106
Joanna Papailiou, Konstaninos J. Bramis, Maria Gazouli, George Theodoropoulos. Stem cells in colon cancer. A new era in cancer theory beginsInternational Journal of Colorectal Disease 2011; 26(1): 1 doi: 10.1007/s00384-010-1022-6
107
Wei Zhan, Xin Liao, Yuan Wang, Lianghe Li, Jin Li, Zhongsheng Chen, Tian Tian, Jingdong He. circCTIC1 promotes the self-renewal of colon TICs through BPTF-dependent c-Myc expressionCarcinogenesis 2019; 40(4): 560 doi: 10.1093/carcin/bgy144
108
Jung Wook Huh, Yeon Sun Park, Jae Hyuk Lee, Hyeong Rok Kim, Myung Geun Shin, Young Jin Kim. CD133 mRNA expression and microsatellite instability in colorectal carcinomaJournal of Surgical Oncology 2010; 102(7): 765 doi: 10.1002/jso.21734
109
Hassan Mansour Hegab, Mahmoud S. Malis, Bassma Mohamed El-Saaba, Ahmed Samy El-Agwany, Alaa Elzarka. Cancer stem cells with positive CD44 marker in advanced malignant epithelial ovarian tumors, and their relation with chemotherapeutic sensitivityEvidence Based Womenʼs Health Journal 2015; 5(4): 175 doi: 10.1097/01.EBX.0000471707.00703.95
110
Tetsuya Tamatani, Natsumi Takamaru, Go Ohe, Kazuya Akita, Takayuki Nakagawa, Youji Miyamoto. Expression of CD44, CD44v9, ABCG2, CD24, Bmi‑1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological factorsOncology Letters 2018;  doi: 10.3892/ol.2018.8703
111
Jaime Antonio Oliver, Raúl Ortiz, Consolación Melguizo, Pablo Juan Álvarez, Jaime Gómez-Millán, Jose Prados. Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinomaBMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-511
112
Jing Han, Toshio Fujisawa, Syed R Husain, Raj K Puri. Identification and characterization of cancer stem cells in human head and neck squamous cell carcinomaBMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-173
113
Kamal Shaik Fakiruddin, Nadiah Ghazalli, Moon Lim, Zubaidah Zakaria, Syahril Abdullah. Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised TumourInternational Journal of Molecular Sciences 2018; 19(8): 2188 doi: 10.3390/ijms19082188
114
A. Shikina, E. Shinto, Y. Hashiguchi, H. Ueno, Y. Naito, K. Okamoto, T. Kubo, S. Fukazawa, J. Yamamoto, K. Hase. Differential Clinical Benefits of 5-Fluorouracil-based Adjuvant Chemotherapy for Patients with Stage III Colorectal Cancer According to CD133 Expression StatusJapanese Journal of Clinical Oncology 2014; 44(1): 42 doi: 10.1093/jjco/hyt168
115
Ji Eun Choi, Jun Sang Bae, Myoung Jae Kang, Myoung Ja Chung, Kyu Yun Jang, Ho Sung Park, Woo Sung Moon. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significanceOncology Reports 2017; 38(3): 1695 doi: 10.3892/or.2017.5790